来自MSN9 小时
Zunveyl: An Improved Alzheimer's Drug With Fewer Side Effects Will Be Available Soon
Fact checked by Nick Blackmer Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne ...
Discovery of new fungi compound leads to hope for potential dementia, Parkinson’s and ...
A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
15 science-based ways to reduce your risk of dementia
Experts say there are ways to reduce our risk of dementia, including diet and exercise, protecting against hearing loss, and ...
Rolling Out10 天
5 ways this cancer drug could revolutionize Alzheimer’s treatment
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
Benzinga.com16 小时
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
Get Real-Time News and Alerts for Your Portfolio Leqembi is indicated for Alzheimer’s disease in patients with Mild Cognitive ...
China Medical System Secures Rights to Alzheimer’s Drug ZUNVEYL
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...